Vyome Holdings, Inc. (HIND)
2.242
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.19
-0.05
(-2.32%)
Pre-Market: 08:26
Vyome Holdings Total Assets (Quarterly) : 9.176M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.176M |
| March 31, 2026 | 10.19M |
| December 31, 2025 | 6.497M |
| September 30, 2025 | 7.045M |
| June 30, 2025 | 9.028M |
| March 31, 2025 | 6.483M |
| December 31, 2024 | 1.382M |
| September 30, 2024 | 5.615M |
| June 30, 2024 | 6.393M |
| March 31, 2024 | 8.231M |
| December 31, 2023 | 10.73M |
| September 30, 2023 | 7.827M |
| June 30, 2023 | 11.85M |
| March 31, 2023 | 16.35M |
| December 31, 2022 | 11.26M |
| September 30, 2022 | 28.46M |
| June 30, 2022 | 41.92M |
| March 31, 2022 | 47.27M |
| December 31, 2021 | 52.90M |
| September 30, 2021 | 90.70M |
| Date | Value |
|---|---|
| June 30, 2021 | 120.00M |
| March 31, 2021 | 17.34M |
| December 31, 2020 | 39.71M |
| September 30, 2020 | 11.96M |
| June 30, 2020 | 13.87M |
| March 31, 2020 | 19.23M |
| December 31, 2019 | 20.39M |
| September 30, 2019 | 24.66M |
| June 30, 2019 | 19.20M |
| March 31, 2019 | 32.37M |
| December 31, 2018 | 30.39M |
| September 30, 2018 | 36.88M |
| June 30, 2018 | 32.47M |
| March 31, 2018 | 40.51M |
| December 31, 2017 | 53.10M |
| September 30, 2017 | 59.08M |
| June 30, 2017 | 64.98M |
| March 31, 2017 | 70.59M |
| December 31, 2016 | 78.78M |
| September 30, 2016 | 18.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.5053M |
| Anika Therapeutics, Inc. | 183.47M |
| Enovis Corp. | 3.766B |
| Edwards Lifesciences Corp. | 13.87B |
| Perspective Therapeutics, Inc. | 392.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.865M |
| Shareholders Equity (Quarterly) | 6.048M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 4.372 |
| Net Debt Paydown Yield | 0.15% |